Abstract
This review summarizes traditional and emerging therapies for SLE. Evidence suggests that the heterogeneity of SLE is a crucial aspect contributing to the failure of large clinical trials for new targeted therapies. A clearer understanding of the mechanisms driving disease pathogenesis combined with recent advances in medical science are predicted to enable accelerated progress towards improved SLE diagnosis and personalized approaches to treatment.
Original language | English (US) |
---|---|
Pages (from-to) | I100-I113 |
Journal | Rheumatology (United Kingdom) |
Volume | 56 |
DOIs | |
State | Published - Apr 2017 |
Keywords
- B cells
- Biological therapies
- Clinical trials
- Immunotherapy
- Methods
- Systemic lupus erythematosus and autoimmunity
ASJC Scopus subject areas
- Rheumatology
- Pharmacology (medical)